Re the brand and what they project as a company.

How important is paying attention to fine detail?

We know it wasn't important to Don (typos in presentations and stumbling over "big" scientific words), so what about the rest of the team?

Even the Brazilian sites haven't appeared here, so is it only management that should be blamed?

We're getting too close to that May date as well, and it looks like we're rudderless.

https://clinicaltrials.gov/ct2/show/NCT04894266?spons=resverlogix&draw=2&rank=1#contacts